Clinical Trials

Showing trials with last updates posted in 2021.

NCT03639324 | WITHDRAWN | PHASE1
0 participants

Rituximab, Idelalisib, and Venetoclax in Relapsed/Refractory CLL/SLL

Study Type:
INTERVENTIONAL
Last Updated:
2021-11-09
Start Date:
2020-10-02
Completion:
2021-10-18
Conditions
  • Chronic Lymphocytic Leukemia
  • CLL
  • Relapsed CLL
  • Refractory Chronic Lymphocytic Leukemia
  • Relapsed Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • SLL
  • Relapsed Small Lymphocytic Lymphoma
  • Refractory Small Lymphocytic Lymphoma
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page